Cargando…

T16. GLUTAMATERGIC CHANGES IN UHR

BACKGROUND: The search for biomarkers may prove significant for short-term identification of UHR individuals (remission/non-remission). On a long-term basis, biomarkers might give the opportunity to delay or prevent psychotic episodes. Disturbances of the neurotransmitters glutamate and GABA have lo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wenneberg, Christina, Broberg, Brian, Rostrup, Egill, Glenthøj, Louise Birkedal, Glenthoj, Birte, Nordentoft, Merete, Kristensen, Tina Dam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888089/ http://dx.doi.org/10.1093/schbul/sby016.292

Ejemplares similares

Supplementary data for a focused review and meta-analysis of (1)H-MRS studies on cerebral glutamate and GABA levels in high-risk of psychosis states
por: Wenneberg, Christina, et al.
Publicado: (2019)

Self-perceived cognitive impairments in psychosis ultra-high risk individuals: associations with objective cognitive deficits and functioning
por: Glenthøj, Louise Birkedal, et al.
Publicado: (2020)

Premorbid adjustment associates with cognitive and functional deficits in individuals at ultra-high risk of psychosis
por: Lundsgaard, Julie, et al.
Publicado: (2022)

F16. GLUTAMATE AND GABA LEVELS IN ANTIPSYCHOTIC-NAïVE SCHIZOPHRENIA PATIENTS ARE ASSOCIATED WITH TREATMENT OUTCOME AFTER 1.5 AND 6 MONTHS
por: Bojesen, Kirsten, et al.
Publicado: (2018)

The effect of cognitive remediation in individuals at ultra-high risk for psychosis: a systematic review
por: Glenthøj, Louise Birkedal, et al.
Publicado: (2017)

M233. EXPERIENTIAL NEGATIVE SYMPTOMS ARE MORE PREDICTIVE OF REAL-LIFE FUNCTIONAL OUTCOME THAN EXPRESSIVE NEGATIVE SYMPTOMS IN CLINICAL HIGH-RISK STATES
por: Birkedal Glenthoej, Louise, et al.
Publicado: (2020)

O3.3. REWARD PROCESSING AS A VULNERABILITY INDICATOR FOR PSYCHOSIS: RESULTS FROM A TWIN STUDY
por: Nielsen, Mette, et al.
Publicado: (2018)

M148. NORMALIZATION IN REWARD PROCESSING DURING INITIAL TREATMENT MAY PREDICT LONG-TERM CLINICAL OUTCOME IN ANTIPSYCHOTIC NAïVE SCHIZOPHRENIA PATIENTS
por: Nielsen, Mette, et al.
Publicado: (2020)

T248. PSYCHOPATHOLOGY IN F2X.X-UNAFFECTED CO-TWINS AS A VULNERABILITY INDICATOR OF PSYCHOSIS
por: Hilker, Rikke, et al.
Publicado: (2018)

Baseline measures of cerebral glutamate and GABA levels in individuals at ultrahigh risk for psychosis: Implications for clinical outcome after 12 months
por: Wenneberg, C., et al.
Publicado: (2020)

S158. REWARD ALTERATIONS IN ANTIPSYCHOTIC NAïVE FIRST-EPISODE-PSYCHOSIS PATIENTS BEFORE AND AFTER TREATMENT WITH A PARTIAL DOPAMINE AGONIST
por: Tangmose, Karen, et al.
Publicado: (2018)

T18. EFFECTS OF COGNITIVE REMEDIATION ON WHITE MATTER IN INDIVIDUALS AT ULTRA-HIGH RISK FOR PSYCHOSIS – A RANDOMIZED, CONTROLLED CLINICAL TRIAL
por: Kristensen, Tina, et al.
Publicado: (2020)

O4.2. HERITABILITY AND CORRELATION TO SCHIZOPHRENIA SPECTRUM DISORDER OF GLUTAMATE AND OTHER NEUROMETABOLITE LEVELS IN ANTERIOR CINGULATE AND LEFT THALAMUS: A REGISTER BASED MAGNETIC RESONANCE TWIN STUDY
por: Legind, Christian, et al.
Publicado: (2018)

No Effects of Cognitive Remediation on Cerebral White Matter in Individuals at Ultra-High Risk for Psychosis—A Randomized Clinical Trial
por: Kristensen, Tina D., et al.
Publicado: (2020)

Widespread higher fractional anisotropy associates to better cognitive functions in individuals at ultra‐high risk for psychosis
por: Kristensen, Tina D., et al.
Publicado: (2019)

Associations Between Cognitive Function and Levels of Glutamatergic Metabolites and Gamma-Aminobutyric Acid in Antipsychotic-Naïve Patients With Schizophrenia or Psychosis
por: Bojesen, Kirsten Borup, et al.
Publicado: (2021)

Examination of gaze behaviour in social anxiety disorder using a virtual reality eye-tracking paradigm: protocol for a case–control study
por: Zeka, Fatime, et al.
Publicado: (2023)

S150. DOPAMINE SYNTHESIS CAPACITY IN ANTIPSYCHOTIC NAïVE FIRST EPISODE PSYCHOTIC PATIENTS
por: Sigvard, Anne, et al.
Publicado: (2018)

F176. CLINICAL CORRELATES OF CORTICAL STRUCTURE IN ANTIPSYCHOTIC-NAïVE SCHIZOPHRENIA PATIENTS BEFORE AND AFTER SIX-WEEK TREATMENT WITH A DOPAMINE D2/3 RECEPTOR ANTAGONIST
por: Jessen, Kasper, et al.
Publicado: (2018)

Social cognition in patients at ultra-high risk for psychosis: What is the relation to social skills and functioning?
por: Glenthøj, Louise B., et al.
Publicado: (2016)

Concurrent functional magnetic resonance imaging and electroencephalography assessment of sensory gating in schizophrenia
por: Bak, Nikolaj, et al.
Publicado: (2013)

Glutamate Levels and Resting Cerebral Blood Flow in Anterior Cingulate Cortex Are Associated at Rest and Immediately Following Infusion of S-Ketamine in Healthy Volunteers
por: Bojesen, Kirsten Borup, et al.
Publicado: (2018)

O9.5. NORMALIZATION OF DISTURBANCES IN PREDICTION ERROR IS RELATED TO TREATMENT RESPONSE AND RELATED TO THALAMIC GLUTAMATE LEVELS IN NON-RESPONDERS
por: Tangmose, Karen, et al.
Publicado: (2020)

T46. THE EFFECT OF COMPREHENSIVE COGNITIVE REMEDIATION IN INDIVIDUALS AT ULTRA-HIGH RISK FOR PSYCHOSIS: A SINGLE-BLIND, RANDOMISED, CLINICAL TRIAL (FOCUS)
por: Birkedal Glenthoej, Louise, et al.
Publicado: (2020)

Glucagon-like peptide-1 analogs against antipsychotic-induced weight gain: potential physiological benefits
por: Ebdrup, Bjørn H, et al.
Publicado: (2012)

Treatment of antipsychotic-associated obesity with a GLP-1 receptor agonist—protocol for an investigator-initiated prospective, randomised, placebo-controlled, double-blinded intervention study: the TAO study protocol
por: Ishøy, Pelle L, et al.
Publicado: (2014)

Negative symptoms assessment in early intervention settings: Implications for early identification and treatment
por: Glenthøj, L.B., et al.
Publicado: (2021)

Alterations of Intrinsic Connectivity Networks in Antipsychotic-Naïve First-Episode Schizophrenia
por: Anhøj, Simon, et al.
Publicado: (2018)

M143. REGIONAL CEREBRAL BLOOD FLOW IN INITIALLY ANTIPSYCHOTIC-NAïVE PATIENTS WITH SCHIZOPHRENIA OR PSYCHOSIS: EFFECTS OF PARTIAL D2 RECEPTOR AGONISM AND ASSOCIATION WITH SYMPTOM IMPROVEMENT
por: Bojesen, Kirsten, et al.
Publicado: (2020)

Treatment response after 6 and 26 weeks is related to baseline glutamate and GABA levels in antipsychotic-naïve patients with psychosis
por: Bojesen, Kirsten B., et al.
Publicado: (2020)

White matter microstructure and sleep-wake disturbances in individuals at ultra-high risk of psychosis
por: Rasmussen, Jesper Ø., et al.
Publicado: (2022)

Cerebral blood flow in striatum is increased by partial dopamine agonism in initially antipsychotic-naïve patients with psychosis
por: Bojesen, Kirsten Borup, et al.
Publicado: (2023)

S246. PSYCHOMETRIC PROPERTIES OF THE DANISH VERSION OF BNSS (BNSS-DA)
por: Gehr, Johannes, et al.
Publicado: (2018)

F236. CLONIDINE NORMALIZES MMN IN SCHIZOPHRENIA PATIENTS ON STABLE MEDICATION
por: Kruiper, Caitlyn, et al.
Publicado: (2018)

The FOCUS trial: cognitive remediation plus standard treatment versus standard treatment for patients at ultra-high risk for psychosis: study protocol for a randomised controlled trial
por: Glenthøj, Louise B, et al.
Publicado: (2015)

The impact of schizophrenia and intelligence on the relationship between age and brain volume
por: Jensen, Maria H., et al.
Publicado: (2018)

Reward Processing as an Indicator of Vulnerability or Compensatory Resilience in Psychoses? Results From a Twin Study
por: Nielsen, Mette Ødegaard, et al.
Publicado: (2022)

Assessment of Cognitive Impairment in Early Intervention Settings
por: Nordentoft, M., et al.
Publicado: (2022)

O6.3. ASSOCIATIONS BETWEEN COGNITIVE FUNCTION AND CORTICAL LEVELS OF GLUTAMATE AND GABA IN ANTIPSYCHOTIC-NAïVE PATIENTS WITH SCHIZOPHRENIA OR PSYCHOSIS
por: Bojesen, Kirsten, et al.
Publicado: (2020)

Is an Early Age at Illness Onset in Schizophrenia Associated With Increased Genetic Susceptibility? Analysis of Data From the Nationwide Danish Twin Register
por: Hilker, Rikke, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1of2h4ut751sjcs9mo0crstfhd